AROMATASE INHIBITORS - EVALUATION OF MAMMARY-TUMOR INHIBITING NON-STEROIDAL COMPOUNDS

被引：0
|
作者：
BATZL, C [1 ]
SCHWARZ, W [1 ]
HARTMANN, RW [1 ]
机构：
[1] UNIV REGENSBURG,INST PHARM,D-8400 REGENSBURG,FED REP GER
来源：
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 1985年 / 109卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：A38 / A38
页数：1
相关论文
共 50 条
  • [21] Testosterone complex and non-steroidal ligands of human aromatase
    Ghosh, Debashis
    Egbuta, Chinaza
    Lo, Jessica
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2018, 181 : 11 - 19
  • [22] AROMATASE INHIBITORS - SYNTHESIS AND EVALUATION OF MAMMARY-TUMOR INHIBITING ACTIVITY OF 3-ALKYLATED 3-(4-AMINOPHENYL) PIPERIDINE-2,6-DIONES
    HARTMANN, RW
    BATZL, C
    JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (08) : 1362 - 1369
  • [23] Non-steroidal aromatase inhibitors based on a biphenyl scaffold: Synthesis, in vitro SAR, and molecular modelling
    Jackson, Toby
    Woo, L. W. Lawrence
    Trusselle, Melanie N.
    Purohit, Atul
    Reed, Michael J.
    Potter, Barry V. L.
    CHEMMEDCHEM, 2008, 3 (04) : 603 - 618
  • [24] Evidence for new non-steroidal human aromatase inhibitors and comparison with equine aromatase inhibition for an understanding of the mammalian active site
    Auvray, P
    Moslemi, S
    Sourdaine, P
    Galopin, S
    Séralini, GE
    Enguehard, C
    Dallemagne, P
    Bureau, R
    Sonnet, P
    Rault, S
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1998, 33 (06) : 451 - 462
  • [25] Nanoemulsion-based transdermal delivery of third-generation steroidal and non-steroidal aromatase inhibitors in preclinical models
    Gao, Lanyang
    Gao, Lin
    Huang, Shiyao
    Sun, Lei
    Li, Mei
    Shen, Chen
    Chen, Youyou
    Tan, Ruihao
    Chen, Yuji
    Zhan, Chengguo
    Wieland, Frank Heinrich
    Liu, Yingying
    Zhang, Yinan
    Luo, Yao
    CELL PROLIFERATION, 2025, 58 (03)
  • [26] Bone safety profile of steroidal aromatase inhibitor in comparison to non-steroidal aromatase inhibitors in postmenopausal women with breast cancer: A network meta-analysis.
    Chen, Shanshan
    Lan, Bo
    Lv, Dan
    Ma, Fei
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [27] ERGOLINES AS POTENTIAL PROLACTIN AND MAMMARY-TUMOR INHIBITORS
    FLOSS, HG
    LLOYDIA-THE JOURNAL OF NATURAL PRODUCTS, 1976, 39 (06): : 468 - 468
  • [28] ECONOMIC EVALUATION OF FULVESTRANT 500 MG VERSUS GENERIC NON-STEROIDAL AROMATASE INHIBITORS IN PATIENTS WITH ADVANCED BREAST CANCER IN NORWAY
    Ekman, M.
    Jacob, J.
    Bjorheim, J.
    VALUE IN HEALTH, 2013, 16 (07) : A414 - A414
  • [29] ERGOLINES AS POTENTIAL PROLACTIN AND MAMMARY-TUMOR INHIBITORS
    CASSADY, JM
    FLOSS, HG
    LLOYDIA-THE JOURNAL OF NATURAL PRODUCTS, 1977, 40 (01): : 90 - 106
  • [30] Effects of a non-steroidal aromatase inhibitor on ovarian function in cattle
    Yapura, M. Jimena
    Mapletoft, Reuben J.
    Singh, Jaswant
    Pierson, Roger
    Naile, Jonathan
    Giesy, John P.
    Chang, Hong
    Higley, Eric
    Hecker, Markus
    Adams, Gregg P.
    REPRODUCTION FERTILITY AND DEVELOPMENT, 2012, 24 (04) : 631 - 640
12345